Purpose: We describe the initial assessment of the peripheral quantitative CT (pQCT) imaging capabilities of a conebeam CT (CBCT) scanner dedicated to musculoskeletal extremity imaging. The aim is to accurately measure and quantify bone and joint morphology using information automatically acquired with each CBCT scan, thereby reducing the need for a separate pQCT exam. Methods: A prototype CBCT scanner providing isotropic, sub-millimeter spatial resolution and soft-tissue contrast resolution comparable or superior to standard multi-detector CT (MDCT) has been developed for extremity imaging, including the capability for weight-bearing exams and multi-mode (radiography, fluoroscopy, and volumetric) imaging. Assessment of pQCT performance included measurement of bone mineral density (BMD), morphometric parameters of subchondral bone architecture, and joint space analysis. Measurements employed phantoms, cadavers, and patients from an ongoing pilot study imaged with the CBCT prototype (at various acquisition, calibration, and reconstruction techniques) in comparison to MDCT (using pQCT protocols for analysis of BMD) and micro-CT (for analysis of subchondral morphometry). Results: The CBCT extremity scanner yielded BMD measurement within ±2-3% error in both phantom studies and cadaver extremity specimens. Subchondral bone architecture (bone volume fraction, trabecular thickness, degree of anisotropy, and structure model index) exhibited good correlation with gold standard micro-CT (error ~5%), surpassing the conventional limitations of spatial resolution in clinical MDCT scanners. Joint space analysis demonstrated the potential for sensitive 3D joint space mapping beyond that of qualitative radiographic scores in application to non-weight-bearing versus weight-bearing lower extremities and assessment of phalangeal joint space integrity in the upper extremities.
INTRODUCTION
Diagnosis and treatment of a spectrum of musculoskeletal diseases stand to benefit from high-quality, accurate imaging and morphological assessment as provided by peripheral quantitative CT (pQCT). For example, osteoporosis presents a growing health burden involving reduction in bone density leading to fragility fractures. Similarly, and particularly in an aging and obese population, osteoarthritis (OA) is an increasingly common degenerative joint disease caused by biomechanical stressors and an attendant dysregulated response characterized by cartilage loss, with concomitant new bone growth, subchondral bony cysts, and other morphologic changes. Rheumatoid arthritis (RA) and other forms of inflammatory arthritis are autoimmune diseases characterized by hypertrophic synovium, cartilage loss, bone erosion, and tendon damage. Such pathologies across a spectrum of bone and joint disorders exhibit signatures in intra-articular morphology, bone density, and bone morphometry [1, 2] , and the ability to more accurately assess these structures quantitatively could provide a means of earlier detection and improved assessment of treatment response.
Bone mineral density (BMD) is commonly measured for characterization of osteoporosis using dual-energy x-ray absorptiometry (DEXA) or quantitative CT (QCT). Other image-based measures present additional, potentially more sensitive assessments of pathology, including bone volume fraction (BV/TV), trabecular thickness (Tb.Th), structure model index (SMI), degree of anisotropy (DA), and high-resolution characterization of the joint space morphology. Such metrics have been conventionally challenged because of the limited spatial resolution of clinical (whole-body) CT scanners 
) mg/mL) 
